Paolo Bonvini
Padova, 35127, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Glypican 3 as target therapy to prevent cell migration and proliferation in rhabdomyosarcoma.
Journal: Scientific reports
Published: December 17, 2024
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.
Journal: JCO precision oncology
Published: October 20, 2022
Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness.
Journal: Oncoimmunology
Published: July 11, 2022
Clinical significance of circulating tumor cells and cell-free DNA in pediatric rhabdomyosarcoma.
Journal: Molecular oncology
Published: October 14, 2021
Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance.
Journal: Oncoimmunology
Published: August 09, 2021
Corrigendum to 'Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner' [Translational Oncology 13 (2020) 100846].
Journal: Translational oncology
Published: January 24, 2021
Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor.
Journal: Frontiers in pediatrics
Published: January 12, 2021
Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma.
Journal: Frontiers in genetics
Published: September 14, 2020
Liquid Biopsy in Pediatric Renal Cancer: Stage I and Stage IV Cases Compared.
Journal: Diagnostics (Basel, Switzerland)
Published: September 10, 2020
Rhabdomyosarcoma Cells Produce Their Own Extracellular Matrix With Minimal Involvement of Cancer-Associated Fibroblasts: A Preliminary Study.
Journal: Frontiers in oncology
Published: August 31, 2020
Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner.
Journal: Translational oncology
Published: June 19, 2020
Prognostic Value of Circulating IGFBP2 and Related Autoantibodies in Children with Metastatic Rhabdomyosarcomas.
Journal: Diagnostics (Basel, Switzerland)
Published: January 27, 2020
Last Updated: 09/26/2026